James B. Weissman

Insider Reports History

Location
San Diego, CA
Signature
/s/ Rob Cutler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James B. Weissman:

Form 4 holding Director

Telesis Bio Inc.

Security class
Common Stock
Shares / value
8,390
Estimated value
$4,430
Report date
24 Jul 2024
Price
$0.5280
Ownership
Direct
Form 4 holding Director

Telesis Bio Inc.

Security class
Stock Option (right to buy)
Shares / value
5,268
Estimated value
Report date
24 Jul 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Operating Officer & EVP

Dicerna Pharmaceuticals Inc

Security class
Restricted Stock Units
Shares / value
0
Estimated value
Report date
28 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Operating Officer & EVP

Dicerna Pharmaceuticals Inc

Security class
Employee Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
28 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by James B. Weissman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .